Celldex Therapeutics, Inc (CLDX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CLDX. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 7,002,530 | $261M | INCREASED |
| State Street | 3,900,427 | $145M | INCREASED |
| Fisher Asset Management | 985,677 | $37M | DECREASED |
| Pictet Asset Management Holding | 917,408 | $34M | DECREASED |
| Assenagon Asset Management | 788,696 | $29M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Harry Penner JR (Director) | AWARD | 26,000 | $886K | 2026-06-25 |
| Herbert J Conrad (Director) | AWARD | 26,000 | $886K | 2026-06-25 |
| James J Marino (Director) | AWARD | 26,000 | $886K | 2026-06-25 |
| Keith L Brownlie (Director) | AWARD | 26,000 | $886K | 2026-06-25 |
| Cheryl Cohen (Director) | AWARD | 26,000 | $886K | 2026-06-25 |
Full institutional holdings, insider history, and congressional trades for Celldex Therapeutics, Inc on SentiSense.